β2-Microglobulin and antiviral therapy for chronic hepatitis type B

Beorchia, 1981, Elevation of serum beta-2 microglobulin in liver diseases, Clin. Chim. Acta, 109, 245, 10.1016/0009-8981(81)90310-7 Berk, 1988, Modulation of interferon/acyclovir effects by indomethacin in chronic hepatitis B, Antiviral Res., 9, 149, 10.1016/0166-3542(88)90199-4 Bianchi, 1977, Acute and chronic hepatitis revisited, Lancet, II, 914 Cooper, 1984, Serum beta-2 microglobulin and C reactive protein concentrations in viral infections, J. Clin Pathol., 37, 1140, 10.1136/jcp.37.10.1140 De Man, 1986, A randomised study comparing a combination of interferon with ‘Deoxyacyclovir’ to no therapy in chronic type B hepatitis, Hepatology, 6, 1166 De Man, 1987, Antivirale combinatietherapie bij chronische hepatitis B, Ned. Tijdschr. Geneesk., 131, 1221 De Man, 1988, Interferon plus descyclovir in chronic hepatitis type B: incidence of virus marker elimination and reactivation, 913 Dooley, 1986, Pilot study of recombinant human alpha-interferon for chronic type B hepatitis, Gastroenterology, 90, 150, 10.1016/0016-5085(86)90087-9 Dusheiko, 1985, Recombinant leucocyte interferon treatment of chronic hepatitis B, Hepatology, 5, 556, 10.1002/hep.1840050406 Fang, 1981, Modified technique of the detection of hepatitis B virus specific DNA-polymerase, J. Virol. Methods, 2, 349, 10.1016/0166-0934(81)90058-6 Hallgren, 1979, Serum beta-2 microglobulin in liver diseases, Scan J. Clin. Lab. Invest, 39, 441, 10.3109/00365517909106129 Katzmann, 1986, Serum beta-2 microglobulin, 61, 752 Lambin, 1986, Serum neopterin and beta-2 microglobulin in anti-HIV positive blood donors, Lancet, II, 1216, 10.1016/S0140-6736(86)92219-1 Lok, 1985, A randomized study of the effects of Adenine Arabinoside 5-Monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication, Hepatology, 5, 1132, 10.1002/hep.1840050612 Nagafuchi, 1986, Expression of beta-2 microglobulin on hepatocytes in acute and chronic type B hepatitis, Hepatology, 6, 20, 10.1002/hep.1840060105 Nyberg, 1985, Serum beta-2 Microglobulin levels in primary biliary cirrhosis, Hepatology, 5, 282, 10.1002/hep.1840050222 Perillo, 1986, Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic hepatitis B, Hepatology, 6, 1129 Pignatelli, 1986, HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection, Hepatology, 6, 349, 10.1002/hep.1840060303 Rashid, 1981, Serum beta-2 microglobulin in hepato-biliary diseases, Clin. Chim. Acta, 114, 83, 10.1016/0009-8981(81)90231-X Redfield, 1986, The Walter Reed staging classification for HTLV-II/LAV infection, N. Engl. J. Med., 314, 131, 10.1056/NEJM198601093140232 Schalm, 1985, Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B, Lancet, II, 358, 10.1016/S0140-6736(85)92498-5 Schalm, 1986, Lymphoblastoid alpha-interferon, weekly, daily and combined with acyclovir for chronic HBeAg positive hepatitis, J. Hepatol., 3, S189, 10.1016/S0168-8278(86)80119-2 Thomas, 1987, A review of the efficacy of adenine arabinoside and lymfoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates, Infection, 15, S26, 10.1007/BF01650108